Benzinga | Aug 12, 2021 04:56PM EDT

KemPharm Q2 EPS $0.18 Misses $0.22 Estimate, Sales $12.00M Miss $12.10M Estimate

KemPharm (NASDAQ:KMPH) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $0.22 by 18.18 percent. This is a 1700 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $12.00 million which missed the analyst consensus estimate of $12.10 million by 0.83 percent. This is a 73.71 percent increase over sales of $6.91 million the same period last year.